Jerzy Trojan

1.6k total citations
62 papers, 1.1k citations indexed

About

Jerzy Trojan is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Biotechnology. According to data from OpenAlex, Jerzy Trojan has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Biotechnology. Recurrent topics in Jerzy Trojan's work include Growth Hormone and Insulin-like Growth Factors (19 papers), Cancer Research and Treatments (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Jerzy Trojan is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (19 papers), Cancer Research and Treatments (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Jerzy Trojan collaborates with scholars based in France, United States and Poland. Jerzy Trojan's co-authors include Joseph Ilan, J Uriel, Thomas R. Johnson, Mark L. Tykocinski, Susan D. Rudin, Judith Ilan, Donald D. Anthony, Maryvonne Ardourel, Rafaël Oriol and Rosella Mollicone and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Annals of the New York Academy of Sciences.

In The Last Decade

Jerzy Trojan

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerzy Trojan France 17 586 325 246 224 219 62 1.1k
Farideh Miraki‐Moud United Kingdom 19 583 1.0× 321 1.0× 264 1.1× 204 0.9× 259 1.2× 33 1.4k
Noel M. Fong United States 8 756 1.3× 298 0.9× 95 0.4× 234 1.0× 82 0.4× 8 1.2k
Tomoaki Inoue Japan 10 1.2k 2.0× 133 0.4× 200 0.8× 133 0.6× 123 0.6× 24 1.7k
Julia Billiard United States 17 1.1k 1.9× 252 0.8× 332 1.3× 194 0.9× 109 0.5× 26 1.6k
N. Shishido United States 3 974 1.7× 131 0.4× 152 0.6× 115 0.5× 89 0.4× 5 1.4k
Tomoo Ueno Japan 20 541 0.9× 327 1.0× 139 0.6× 197 0.9× 1.5k 7.0× 23 2.2k
Paolo Salerno Italy 16 667 1.1× 379 1.2× 254 1.0× 123 0.5× 116 0.5× 31 1.1k
Jason Gill Switzerland 17 632 1.1× 195 0.6× 90 0.4× 158 0.7× 1.1k 5.0× 19 1.9k
Ann M. Pace United States 6 977 1.7× 458 1.4× 154 0.6× 174 0.8× 304 1.4× 6 1.8k
William Benedict United States 6 912 1.6× 37 0.1× 295 1.2× 164 0.7× 159 0.7× 9 1.7k

Countries citing papers authored by Jerzy Trojan

Since Specialization
Citations

This map shows the geographic impact of Jerzy Trojan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerzy Trojan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerzy Trojan more than expected).

Fields of papers citing papers by Jerzy Trojan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerzy Trojan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerzy Trojan. The network helps show where Jerzy Trojan may publish in the future.

Co-authorship network of co-authors of Jerzy Trojan

This figure shows the co-authorship network connecting the top 25 collaborators of Jerzy Trojan. A scholar is included among the top collaborators of Jerzy Trojan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerzy Trojan. Jerzy Trojan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trojan, Jerzy. (2018). New Approach of PCR Technology for IGF-I Evaluation. Biomedical Journal of Scientific & Technical Research. 8(4). 1 indexed citations
2.
Trabado, Séverine, et al.. (2015). Characterization of effector components from the humoral and cellular immune response stimulated by melanoma cells exhibiting modified IGF-1 expression. Biomedicine & Pharmacotherapy. 70. 53–57. 2 indexed citations
3.
Trojan, Jerzy, Ming Wei, Piotr Kopiński, et al.. (2010). Antisense anti IGF-I cellular therapy of malignant tumours: Immune response in cancer patients. Biomedicine & Pharmacotherapy. 64(8). 576–578. 7 indexed citations
4.
Ardourel, Maryvonne, et al.. (2007). A new putative target for antisense gene therapy of glioma: Glycogen synthase. Cancer Biology & Therapy. 6(5). 719–723. 5 indexed citations
5.
Liu, Y., Jian Zhao, Lu Yang, et al.. (2003). Antisense IGF-I for Hepatocellular Carcinoma. Humana Press eBooks. 45. 221–235. 1 indexed citations
6.
Obrępalska‐Stęplowska, Aleksandra, et al.. (2003). Analysis of Coding and Promoter Sequences of the IGF-I Gene in Children with Growth Disorders Presenting with Normal Level of Growth Hormone. Journal of Pediatric Endocrinology and Metabolism. 16(9). 1267–75. 6 indexed citations
7.
Kopiński, Piotr, Ming Wei, Aleksandra Głogowska, et al.. (2002). IGF-I: from diagnostic to triple-helix gene therapy of solid tumors.. Acta Biochimica Polonica. 49(4). 979–990. 13 indexed citations
8.
Kalamarides, Michel, Alexander Shevelev, Jean‐Christophe François, et al.. (2001). Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma. Molecular Pathology. 54(4). 230–239. 20 indexed citations
9.
François, Jean‐Christophe, et al.. (2000). Alterations in tumorigenicity of embryonal carcinoma cells by IGF-I triple-helix induced changes in immunogenicity and apoptosis. Life Sciences. 68(3). 307–319. 10 indexed citations
10.
Bouchaud, C., Dominique Hénin, Marc Sanson, et al.. (2000). Expression of insulin-like growth factor-I in rat glioma cells is associated with change in both immunogenicity and apoptosis. Neuroscience Letters. 281(1). 13–16. 5 indexed citations
11.
Achard, Sophie, Zohair Mishal, Jerzy Trojan, et al.. (1998). Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNA. Journal of Hepatology. 29(5). 807–818. 32 indexed citations
12.
Buisson, Yves, Michel Arborio, C. Lafarge‐Frayssinet, et al.. (1998). Use of the IGF-I Antisense Strategy in the Treatment of the Hepatocarcinoma. Advances in experimental medicine and biology. 451. 35–42. 12 indexed citations
13.
Trojan, Jerzy, Đức Việt Hồ, C. Lafarge‐Frayssinet, et al.. (1996). [Immunotherapy of tumors expressing IGF-I].. PubMed. 190(1). 165–9. 2 indexed citations
14.
Trojan, Jerzy, Thomas R. Johnson, Olivier Farges, et al.. (1995). Expression of serum albumin and of alphafetoprotein in murine normal and neoplastic primitive embryonic structures. Molecular Reproduction and Development. 42(4). 369–378. 3 indexed citations
15.
Trojan, Jerzy, Thomas R. Johnson, Susan D. Rudin, et al.. (1993). Treatment and Prevention of Rat Glioblastoma by Immunogenic C6 Cells Expressing Antisense Insulin-Like Growth Factor I RNA. Science. 259(5091). 94–97. 262 indexed citations
16.
Trojan, Jerzy, et al.. (1991). Alpha-Fetoprotein Uptake by Differentiating Neuroretinal Structures of the Chick Embryo. Developmental Neuroscience. 13(3). 164–170. 10 indexed citations
17.
Trojan, Jerzy, et al.. (1987). Localization of H Blood Group Antigen in Ectoblastic Derivatives of Murine Teratocarcinoma. Tumor Biology. 8(1). 9–18. 1 indexed citations
18.
Gresser, Ion, et al.. (1984). Inhibitory Effect of Mouse Interferon on the Growth of an Embryonal Carcinoma in Mice. Journal of Interferon Research. 4(3). 375–381. 5 indexed citations
19.
Trojan, Jerzy, et al.. (1983). Immunocytochemical Quantitative Study of Alpha-Fetoprotein in Normal and Neoplastic Neural Development. Developmental Neuroscience. 6(4-5). 251–259. 7 indexed citations
20.
Trojan, Jerzy, et al.. (1983). In vitro Uptake of Exogenous α-Fetoprotein by Chicken Dorsal Root Ganglia. Developmental Neuroscience. 6(2). 111–117. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farideh Miraki‐Moud Breakdown of academic impact, for papers by Noel M. Fong Breakdown of academic impact, for papers by Tomoaki Inoue Breakdown of academic impact, for papers by Julia Billiard Breakdown of academic impact, for papers by N. Shishido Breakdown of academic impact, for papers by Tomoo Ueno Breakdown of academic impact, for papers by Paolo Salerno Breakdown of academic impact, for papers by Jason Gill Breakdown of academic impact, for papers by Ann M. Pace Breakdown of academic impact, for papers by William Benedict
Rankless by CCL
2026